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Methylome and transcriptome 
maps of human visceral and 
subcutaneous adipocytes reveal 
key epigenetic differences at 
developmental genes
stephen t. Bradford1,2,3, Shalima S. Nair1,3, Aaron L. statham1, Susan J. van Dijk2, 
Timothy J. peters  1,3,4, Firoz Anwar  2, Hugh J. French  1, Julius Z. H. von Martels1, 
Brodie Sutcliffe2, Madhavi P. Maddugoda1, Michelle peranec1, Hilal Varinli1,2,5, 
Rosanna Arnoldy1, Michael Buckley1,4, Jason P. Ross2, Elena Zotenko1,3, Jenny Z. song1, 
Clare Stirzaker1,3, Denis C. Bauer2, Wenjia Qu1, Michael M. Swarbrick6, Helen L. Lutgers1,7, 
Reginald V. Lord8, Katherine samaras9,10, Peter L. Molloy  2 & Susan J. Clark  1,3
Adipocytes support key metabolic and endocrine functions of adipose tissue. Lipid is stored in 
two major classes of depots, namely visceral adipose (VA) and subcutaneous adipose (SA) depots. 
Increased visceral adiposity is associated with adverse health outcomes, whereas the impact of SA 
tissue is relatively metabolically benign. The precise molecular features associated with the functional 
differences between the adipose depots are still not well understood. Here, we characterised 
transcriptomes and methylomes of isolated adipocytes from matched SA and VA tissues of individuals 
with normal BMI to identify epigenetic differences and their contribution to cell type and depot-specific 
function. We found that DNA methylomes were notably distinct between different adipocyte depots 
and were associated with differential gene expression within pathways fundamental to adipocyte 
function. Most striking differential methylation was found at transcription factor and developmental 
genes. Our findings highlight the importance of developmental origins in the function of different fat 
depots.
Adipocytes are the predominant cell type of adipose tissue and central to its key metabolic and endocrine func-
tions, including storing or releasing triglycerides, and secreting adipokines that regulate metabolic, hormonal and 
inflammatory pathways1,2. In mammals lipid is primarily stored in two major classes of depot, visceral adipose 
depots and subcutaneous adipose depots2,3. While the different depots share many properties, there are impor-
tant functional differences between visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT). These 
include differences in lipolysis, insulin sensitivity, adipokine secretion and inflammatory and immune function4,5. 
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Increased visceral adiposity has been associated with many of the poor health outcomes linked to obesity6,7: 
type 2 diabetes mellitus, heart disease, and certain types of cancer8,9, as well as increased mortality10. In contrast, 
SAT, particularly lower-body SAT, is considered relatively metabolically benign11,12. However, molecular features 
associated with the functional differences between these similar, yet distinct, cell types are not well understood.
The epigenome is essential in enforcing, and sequentially restricting cell specific expression patterns 
throughout human development, and in maintaining cells in their appropriate functional states. The advent of 
next-generation sequencing technologies has enabled the creation of epigenome-wide data sets to provide insights 
into the molecular characteristics that underpin differences in normal cell function. As adipocytes from visceral 
and subcutaneous depots (VA and SA respectively) perform many of the same functions, we were interested to 
compare the epigenomes and transcriptomes of these similar yet distinct cell types. Comparative genome-wide 
studies have previously used microarray-based analysis of whole adipose tissues which are a mixture of different 
cell types13–15. Whole methylome analysis of subcutaneous tissue16 or capture bisulphite sequencing of visceral 
tissue17 have been reported separately for each tissue type but not for isolated cells. Here, we isolated adipocytes 
from matched SAT and VAT of individuals with a normal BMI to comprehensively characterise each of the tran-
scriptomes and DNA methylomes to determine the epigenetic differences and their potential contribution to 
cell type and depot-specific function. Our results show that the cell-type specific DNA methylation profiles were 
associated with differential gene expression within pathways fundamental to adipocyte function and highlight the 
importance of developmental origins in the function of different fat depots.
Results
Distinct DNA methylomes and transcriptomes characterise visceral and subcutaneous adipo-
cytes. To characterise key differences in the epigenomes of adipocytes from different depots we generated 
comprehensive epigenome and transcriptome maps of isolated subcutaneous and SA and VA. Whole genome 
bisulphite sequencing (WGBS) and stranded RNA sequencing (RNA-seq) was performed on isolated and match-
ing SA and VA (Fig. 1a) from a core set of three females with a healthy body weight. Comparison with public 
methylome microarray data on whole adipose tissues from a larger cohort18 indicates that the three individuals 
are representative of normal weight subjects (Supplementary Information). Supplementary Table S1 summarises 
the WGBS (>25X coverage), RNA-seq data and patient characteristics, including blood biochemistry. SA and 
VA were also compared to whole VAT and peripheral blood leukocytes (PBL). WGBS methylation data analysis 
was further supported by Illumina Infinium Bead Chip Human 450 arrays (450 K arrays) on five individuals 
(Supplementary Information and Supplementary Table S9).
We first identified genes that were differentially expressed between SA and VA from the RNA-seq data. A 
total of 2,943 genes were identified, 1,582 down and 1,361 up in matched SA compared with VA (Supplementary 
Tables S2, S3). Greater than 91% of the differentially expressed genes were protein coding, with 1,412 down reg-
ulated and 1,281 up regulated in SA compared with VA. Figure 1b shows a volcano plot of gene expression (see 
also Supplementary Information). The expression profiles of isolated adipocytes are in broad agreement with 
differential gene expression profiles of VAT and SAT using microarray platforms13. Genes important in endocrine 
function, including ITLN1 (Omentin) (Fig. 1b)19, CCL3 (MIP-1a) and TNF were elevated in expression in VA, 
and Leptin (LEP) and Osteonectin (SPARC) higher in SA. A number of genes involved in the insulin signalling 
pathway also show high differential expression, including the lncRNA CRNDE (Fig. 1b) and RBP4 (Retinol bind-
ing protein 4) more highly expressed in SA and PTPN6 and PTPRD more highly expressed in VA (Supplementary 
Tables S2, S3). Pathway analysis using GOseq for the differentially expressed genes identified 1,466 enriched terms 
(FDR, p < 0.05) (Fig. 1c, Supplementary Table S4). Notably many of the highly enriched terms highlighted char-
acteristics that are known to differ between the two adipose depots, including regulation of cytokine production, 
extracellular matrix, fat cell differentiation, fatty acid metabolic process, regulation of lipid metabolic process, 
innervation (axon guidance) and angiogenesis (Fig. 1c and Supplementary Table S4). Functions such as adipokine 
secretion and lipid storage are recognised intrinsic properties that distinguish visceral and subcutaneous adipo-
cytes. However, the data further indicate that many of the gene expression differences between the isolated adi-
pocytes also relate to whole tissue functions such as leukocyte migration, angiogenesis and extracellular matrix.
Second, analysis of WGBS data (Fig. 1d), and using the 450 K methylome data for validation (Supplementary 
Fig. S1), demonstrated a clear clustering by DNA methylation for each cell type. In the first dimension adipocytes 
and PBL separate, while SA and VA separate in the second dimension. Across the genome we found that SA 
and VA are hypomethylated relative to PBL, especially at CpG shores and non-island regions (Supplementary 
Information and Supplementary Fig. S1). Interestingly, purified VA cells and corresponding tissue (VAT) cluster 
closely even though VAT is a mixture of different cell types. Comparison with published methylation data on 
adipose tissue also show that SA and VA segregate with SAT and VAT respectively (Supplementary Information 
and Supplementary Fig. S1). Consistent with the tight clustering within cell types, individual methylation profiles 
also show high concordance between subjects (Fig. 1e). Analysis of the 450k array data demonstrates that vari-
ance was exceptionally low genome-wide within each cell type across individuals (median Standard Deviation of 
individual CpG sites ~1.5%, Supplementary Fig. S2). Exemplary distinct VA and SA DNA methylation profiles of 
TBX5, which is implicated in early steps of adipocyte differentiation and ISL2, a homologue of adipogenic factor 
ISL1, are shown in Fig. 1e (WGBS) and Supplementary Fig. S2 (450 K). Notably the promoter associated TBX5 
CpG island is hypermethylated in SA relative to VA, VAT and PBL, whereas for ISL2 VA and VAT display high 
gene body methylation relative to SA and PBL.
Third, to explore how the differences in methylation profiles relate to the functional characteristics of VA 
and SA, we used BSmooth20 to identify Differentially Methylated Regions (DMRs) in WGBS data. Strikingly, we 
found 67,048 DMRs with a ≥10% difference in methylation averaged across the region (ΔMe of ≥0.1). Most of 
the DMRs (53,456) displayed hypermethylation in VA (VA-DMR), while 13,592 were hypermethylated in SA 
(SA-DMR) (Fig. 2a, genomic regions listed in Supplementary Tables S7 and S8). DMRs identified using 450 K 
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arrays showed high concordance with WGBS DMRs (Supplementary Information and Supplementary Table S9). 
In total the WGBS DMRs encompass ~43 Mb or 1.4% of the genome. The majority of SA- and VA-DMRs were 
located either within gene bodies (~40%) and promoter regions (+/− 2 kb of Transcription start sites (TSS) 20%), 
Supplementary Fig. 3. With a more stringent DNA methylation distinction (ΔMe ≥0.3), 777 VA-DMRs and 
215 SA-DMRs were identified. These “High DMRs” were found closer to the TSS of genes and had higher CpG 
density; there was a strong trend for increasing overlaps with CpG islands and shores with increasing ΔMe (χ2 
292.3 and 233.6 respectively, p < 22.e-16) with 4.5% and 27.8% of ≥0.3 DMRs overlapping CpG Islands or Shores 
respectively (Supplementary Fig. S3). An example of DMRs at the NKX2-5 locus is shown in Fig. 2b. We also 
examined whether single nucleotide polymorphisms (SNPs) that have been associated with either fat distribution 
(waist-hip ratio) or obesity were enriched in regions of SA-VA DMRs. A marginally significant association of 
DMRs with body fat distribution SNPs was identified21, but none was seen with obesity SNPs22 (Supplementary 
Information).
Figure 1. Methylomes of adipocytes cluster based on fat depot. (a) Diagrammatic representation of samples taken 
and study design (b) Volcano plot of differences in expression between SA and VA in whole RNA-seq. (main) 
Red points FDR < 0.001, orange points logFC >2, green points FDR < 1e-6 and logFC >5. (right box) Points 
with FDRs less than 1e-50 removed, orange dots FDR < 0.001 and logFC >2. (c) Gene ontology of biological 
processes enriched in genes differentially expressed between SA and VA. Selected gene symbols of genes DE in 
each term displayed. Differential expression was identified using whole RNA-seq. X-axis: Negative log10 FDR 
enrichment. (d) Multi-Dimensional Scaling (MDS) of WGBS samples from each patient based on methylation at 
all (17,483,788) CpGs with 5x coverage. (e) Browser shots of WGBS methylation levels across TBX5 and ISL2 loci 
for VAT, VA, SA and PBL samples from all patients. Arrows indicate direction of transcription. Green bars indicate 
CpG Islands. SAT = subcutaneous adipose tissue, SA = isolated subcutaneous adipocytes, VAT = visceral adipose 
tissue, VA = isolated visceral adipocytes, PBL = peripheral blood leukocytes, WGBS = whole genome bisulphite 
sequencing, 450 K = Illumina Infinium Human Methylation 450 BeadChip arrays, whole RNA-seq = Ribosomal 
RNA reduced RNA-seq. CpGI = CpG Islands, FDR = False Discovery Rate, LogFC = log of fold change.
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Figure 2. Magnitude of differential methylation between SA and VA correlates with different gene functions. 
(a) Stratification of Differentially Methylated Regions (DMRs) between SA and VA (SAVA DMRs) by average 
difference in methylation across the region (ΔMe), Down = lower methylation in SA compared to VA (VA-
DMRs) and Up = higher methylation in SA compared to VA (SA-DMRs). (b) UCSC browser image of NKX2-5 
gene. Tracks include WGBS methylation tracks for VA, SA, VA-SA differential methylation, SA-VA DMR, CpG 
islands. (c,d) Overarching Gene Ontology Biological Processes terms generated using Revigo52 based on top 100 
GO terms generated in custom GOseq (see methods) (c) Biological processes terms based on SAVA DMRs 0.1 
to <0.3 (d) Biological processes terms based on SAVA DMRs >0.3. (e) Percentage of DMRs with transcription 
factors as nearest protein coding gene. X-axis = genes stratified by absolute value of ΔMe, y-axis = the 
percentage of DMRs that have a transcription factor as nearest protein coding gene (TF) or DMRs that do not 
have a transcription factor as nearest protein coding gene (non-TF). Table shows examples of transcription 
factors that are the closest protein coding gene to DMRs with absolute ΔMe >0.4. (f) Diagrammatic 
representation of DMRs within the HOX gene clusters. Y-axis = ΔMe, x-axis = HOX clusters.
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DNA methylation profiles highlight different developmental origins. To identify how DNA meth-
ylation is associated with the functional differences between SA and VA, we used Gene Ontology (GO) analysis 
to identify pathways enriched for regions that were differentially methylated between SA and VA. Using GOseq 
we found enrichment for terms relating to cell function, as well as development (Supplementary Fig. S4). We 
next examined the GO of DMRs of either Low (Low DMRs, 0.1 < ΔMe < 0.3) or High (High DMRs, ΔMe ≥ 0.3) 
magnitude and found a striking split in the terms that were enriched (Fig. 2c,d). Low DMRs (n = 66,056) were 
enriched for genes in pathways relating to cell function and enzyme activity (Fig. 2c, Supplementary Table S10). 
In contrast, for the 992 High DMRs a striking enrichment for DNA binding and developmental processes related 
to regionalisation was seen (Fig. 2d, Supplementary Table S11). A similar dichotomy was reflected in the enriched 
GO Molecular Function and Cellular Compartment terms (Supplementary Fig. S4).
Given the enrichment of terms relating to DNA binding in the GO analysis we compared DMR location rela-
tive to transcription factor (TF) genes23 and found that DMRs associated with TF genes tend to have larger ΔMe 
than all DMRs (Fig. 2e, Supplementary Table S12). Indeed 54.3% of highest DMRs have a transcription factor as 
their nearest protein-coding gene (Fig. 2e, trend χ2 360.7, p < 2.2e-16). Notably, many of these TFs are essential 
for embryonic organization, driving cell type specification and controlling positional identity during embryonic 
development. For example we found that 31 of the 39 protein coding HOX genes24 were associated with DMRs 
(Fig. 2f – Supplementary Fig. S5). A number of the highest DMRs between SA and VA were in other gene families 
important in establishing cell identity and the organisation of mesodermally derived tissues, such as adipose 
tissue. These included the developmental transcription factors: PITX (1 and 2), TBX (4, 5, 15, 18), IRX (2, 3, 5) 
and NKX (2–3, 2–5, 3–2) (Supplementary Fig. S6)25–29. Recent 450 K data on adipose tissues has also identified 
enrichment of DMRs associated with developmental genes18. Our analysis of isolated adipocytes expands this set 
considerably and provides the base pair resolution necessary to characterise potential regulatory elements.
Together these findings highlight the enrichment of distinct DMRs close to developmental transcription fac-
tors and support the finding that visceral and subcutaneous depots may have different developmental origins30.
Differential DNA methylation between SA and VA is associated with differential expression 
of development genes and genes important for adipocyte function. Integrating differential gene 
expression with differential methylation, we identified that ~66.1% of the differentially expressed genes had 
DMRs within their gene body and/or promoter. The greater the magnitude of the DMR the more likely the gene 
was to be differentially expressed (Supplementary Fig. S8). This relationship was particularly apparent for DMRs 
in the promoters of protein coding genes (Fig. 3a, trend χ2 154.5, p < 2.2e-16). Interestingly, the promoter regions 
of differentially expressed protein coding genes with High DMRs are less methylated than the promoters of other 
protein coding genes (Fig. 3b and Supplementary Fig. S8). In fact, 56% of High DMRs that are within the promot-
ers of differentially expressed protein coding genes are in regions where one cell type is lowly methylated (average 
methylation ≤ 0.25). In contrast only 9% of the remaining promoter DMRs are in regions where one cell type has 
average methylation ≤ 0.25 (χ2 67.6, p = 1.37e-14). Of these High DMRs associated with protein-coding gene 
promoters, 64.4% overlap with CpG island shores compared with 4.7% located in islands themselves. In general, 
these High DMRs can visually be equated to “cliffs” rising from a methylation plain rather than “ravines” from 
a plateau (Fig. 3e,f, Supplementary Fig. S9). Consistent with this, High DMRs within the promoters of differen-
tially expressed genes were preferentially located in DNA Methylation Valleys (DMV, Supplementary Fig. S8 and 
Supplementary Information). Thus, SAVA DMRs present in CpG shores often display a cliff profile flanking the 
TSS, with sharp elevation in methylation on one or both sides of an unmethylated CpG island.
To better understand how differences in DNA methylation between SA and VA may contribute to adipocyte 
function we focused on genes that were differentially expressed between SA and VA and that were associated with 
promoter DMRs (DE-DM genes). Here we chose a threshold (ΔMe ≥ 0.2) to focus on those DMRs that were 
more likely to have a regulatory function. In total 448 differentially expressed genes, associated with 589 DMRs, 
were identified and manually curated (Supplementary Tables S13 and S14, Fig. 3d). We divided our DE-DM genes 
into four categories based on the direction of their difference in expression and methylation between VA and SA 
(Fig. 3c). Many of these genes were involved in processes important for adipocyte functioning (Fig. 3d). These 
included genes involved in processes that display functional differences between SAT and VAT, including in lipid 
droplet formation and lipid mobilisation, angiogenesis and extracellular matrix remodelling. Specific examples 
are discussed further in Supplementary Information and Supplementary Table S14. Remarkably we found that 13 
DE-DM genes were among the 43 identified by Keller et al. in their array-based comparison of 18 non-obese sub-
jects15, despite the differences in technology and our data deriving from isolated adipocytes, rather than adipose 
tissue. Numerous genes with polymorphisms linked to fat distribution and waist-hip ratio were also differentially 
expressed and associated with promoter DMRs (Fig. 3d and Supplementary Table S14); these included the devel-
opmental genes HOXA11 and TBX1521.
Differential expression of developmental genes, including HOX and TBX family members, between omental 
VAT and abdominal SAT, and between different SAT depots has previously been reported31. Our data highlight 
that many TF genes with important developmental roles in adipogenesis and more broadly in regionalisation 
(Fig. 3d) are both differentially expressed and are marked by distinct DNA promoter methylation profiles in SA 
and VA. Indeed, this set of genes includes many of those with the largest DMRs (Supplementary Fig. S8). The 
likelihood that TF genes are differentially expressed between SA and VA increases with the strength of the DMR 
with 16/23 (70%) genes with DMRs >0.4 being differentially expressed (Supplementary Fig. S8, χ2 trend, 67.63, 
p = 1.374e-14). For example WT1, expression of which has been associated with visceral adipocyte development 
in mice30, is more highly expressed in VA relative to SA and is marked by differential methylation of >30%. 
The promoters of the developmental genes BARX1, EBF2, NKX3-2 and GATA2 are also marked by promoter 
DMRs with ΔMe ≥0.3, Supplementary Table S13. Among other genes that are marked by differential promoter 
methylation and are more highly expressed in VA (Fig. 3d) are engrailed (EN1), HOXB6 and the key adipocyte 
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transcription factor ZNF423. In contrast to visceral depots, the developmental origins of subcutaneous depots 
remain largely unknown30. In SA we see numerous developmental transcription factors that are epigenetically 
marked and overexpressed relative to VA. These include multiple members of the HOX gene families (including 
HOXA9, A10 and A11, HOXC6 (previously described15), C8 and C10, HOXD3 and D8), TBX genes (TBX4, 15 
and 18) as well as IRX3, PITX2, ALX1 and DMRT3. These genes provide a gene expression and DNA methylation 
signature that is indicative of the different development origins of SA and VA.
Elevated DNA methylation in promoter regions is commonly associated with reduced gene expression. 

























































































































































































































































































Figure 3. Differential DNA Methylation associated with differential gene expression. (a) Barplot of protein 
coding genes stratified according to those with promoter DMRs between 0.1 to <0.2, 0.2 to <0.3, 0.3 to <0.4, 
>0.4 and all protein coding genes (All). χ2 trend was calculated across the four ΔMe groups. The percentage of 
these genes are then split by whether they are differentially expressed (DE – grey) or not differentially expressed 
(Not DE – black). Y-axis = percentage DE or Not DE, x – axis gene stratification. (b) Plot of methylation 
level in VA across promoters containing DMRs. Loess regression was used to fit a curve representing overall 
methylation levels in VA, 4 kb either side of the TSS, of four groups of genes. Left panel shows plots for 
promoters containing DMRs with ΔMe ≥ 0.3 and right panel those with ΔMe = 0.2 to <0.3. Profiles for 
DE genes are shown in red and for non-DE genes in blue. X-axis = relative position to the TSS of genes, 
y-axis = methylation level. (left) DMRs – Δme ≥ 0.3, (right) DMRs - ΔMe 0.2 to <0.3. (c) Table enumerating, 
into four groups, differentially methylated regions within 2 kb of TSS (>0.2 ΔMe) associated with differentially 
expressed genes. Grouping is by differential methylation, Up or Down, with respect to SA, and differential 
expression, Up or Down, with respect to SA. The numbers of genes associated with DMRs are shown in 
brackets; in seven cases a DE gene is associated with both SA- and VA-DMRs. (d) Examples of genes identified, 
and grouped, by differential expression and methylation, as in figure (c). Genes are categorized into columns 
of biological processes with which they are associated. (e) (f) UCSC browser image of GATA2 and HOXC10. 
Tracks include WGBS methylation tracks for VA, SA, VA-SA differential methylation, CpG islands, and paired 
RNA-seq for SA and VA Blue columns highlight DNA methylation cliffs.
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methylation. However, surprisingly, for the remaining 38% of genes, differences in gene expression and promoter 
methylation were concordant, that is elevated methylation within 2 kb of the TSS was associated with increased 
gene expression. We found that the concordant genes were significantly enriched for TFs and commonly located 
in DMVs (Supplementary Fig. S8). Examples (blue shade) are shown in Fig. 3e,f (GATA2 and HOXC10 and 
Supplementary Fig. S9 (ALX1, DMRT3, EN1, IRX3, TBX18, and SLFN12L). In these examples the differential 
methylation shortens the unmethylated region surrounding the TSS in the higher-expressing cell type.
The differences in DNA methylation at these transcription factor promoters are often of high magnitude and 
are characteristically in DMVs suggesting that DNA methylation plays a key regulatory role in defining fat depots 
during development.
Identification of regulatory elements from methylome profiles. We applied MethylSeekR32 to the 
DNA methylation profiles of VA, SA and PBL samples to identify putative regulatory elements, as characterised 
by methylation levels and CpG site density. Unmethlyated regions (UMRs) have previously been reported to 
represent active promoters and low-methylated regions (LMRs) to represent active enhancers33 (Supplementary 
Tables S15–20). Additionally, we identified extended regions of minimal DNA methylation (DMVs) commonly 
associated with genes regulating early development34 (Supplementary Information, Supplementary Table S21). 
Venn diagrams (Fig. 4a) show the overlaps of UMRs, LMRs and DMVs identified in SA, VA and PBL cells. The 
predictive classifications of these elements were validated using available (NIH Roadmap Epigenomics Project) 
chromatin data of subcutaneous adipocytes (Fig. 4b).
Of the 24,662 UMRs identified, 18,855 (76%) were shared between the VA, SA and PBL DNA (Fig. 4a, 
Supplementary Fig. S10). A further 2,395 (9.7%) were shared between the two adipocyte types alone while only 
12.6% were specific to an individual cell type, including 580 VA specific and 1551 SA specific UMRs. This sub-
stantiates that the majority of UMRs are not tissue specific and are unmethylated independent of expression of 
the associated gene. UMRs typically encompass regions spanning ~1000 bp (Fig. 4c and Supplementary Fig. S10) 
and are found near TSSs (Supplementary Fig. S10), with >70% of UMRs overlapping a TSS (Supplementary 
Tables S15–17). We found that SA UMRs correlate strongly with the active promoter marks (H3K4me3 and 
Figure 4. DNA methylation and regulatory elements. (a) Venn diagrams showing number of shared and tissue 
specific UMRs, LMRs, DMVs across SA, VA and PBL. (b) Signal intensity plots of subcutaneous adipocyte 
H3K4me1, H3K4me3, H3K27ac and H3K27me3 levels (from The Roadmap Epigenetics Project) across SA 
UMR, LMR and DMV features relative to the centre of each feature. Individual regions (rows) are stacked 
from the lowest to highest mean methylation across the regions. Signal intensity is a gradient of blue at lowest 
intensity and red at highest. (c) Smoothed averages of VA methylation levels at LMRs (yellow), UMRs (red) and 
DMVs (blue). Plots are centred at the midpoints of each feature.
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H3K27ac) and enhancer marks (H3K27ac and H3K4me1) (Fig. 4b). Interestingly H3K4me1 displays a ‘wishbone’ 
distribution bordering the H3K4me3 mark and its binding is enriched at UMRs with a lower density of DNA 
methylation (Fig. 4b).
LMRs are 3 to 6 times more frequent than UMRs, in all tissues (Supplementary Fig. S10) and notably are more 
tissue specific, with less than 16% (22,154) of 143,464 identified LMRs shared between PBL, SA and VA samples 
and 28% (3,991) between SA and VA samples (Fig. 4a), supporting the overall tissue specificity of enhancer 
elements. LMRs are generally shorter than UMRs, a few hundred bp (Fig. 4c and Supplementary Fig. S10), are 
further from the nearest TSS, with a median distance of ~10 kb (Supplementary Fig. S10) and are characterised 
by enrichment for enhancer marks H3K4me1 and H3K27ac and deplete of H3K4me3 and the repressive mark 
H3K27me3 (Fig. 4b). To assess the utility of UMRs and LMRs for identifying regulatory elements in SA and VA, 
we performed GO analysis comparing adipocyte-specific elements (i.e. those common to SA and VA, but not 
PBL) with PBL-specific elements. Tissue-specific UMRs were found to be enriched in terms associated with the 
difference in cell type. For example, adipocyte-specific UMRs were enriched for lipid related terms including 
triglyceride biosynthetic process (Supplementary Fig. S11, Supplementary Table S22), while PBL-specific UMRs 
were enriched for blood and immune terms such as leukocyte migration (Supplementary Fig. S11). In contrast, 
tissue specific LMRs showed a wide range of enriched terms including those relating to extracellular matrix, 
blood vessel morphogenesis and developmental processes, supporting their role as regulatory elements in a wide 
range of pathways important in adipocyte biology (representative example, SA LMRs Supplementary Fig. S11, 
Supplementary Information, Supplementary Table S22).
DMVs were found at lower frequencies ~500 to 600 in each sample (Supplementary Fig. S10). The least 
methylated DMVs were associated centrally with the active marks H3K27ac and H3K4me3. In contrast the 
modest increases in methylation levels (4–10%) were accompanied by an increased enrichment of the repres-
sive H3K27me3 mark (Fig. 4b). Consistent with Xie and colleagues34, genes associated with DMVs were highly 
enriched for transcription and developmental processes (Supplementary Fig. S11, Supplementary Table S22).
Preferential association of transcription factor binding sites with regulatory regions inferred 
from DNA methylation profiles. Transcription factors can associate combinatorially with gene regulatory 
elements to drive cell type-specific gene expression. To investigate differences in the transcriptional landscape 
between SA and VA we overlapped publicly available TF ChIP-seq data with the potential regulatory elements 
we had identified from WGBS. We initially used binding sites for the key adipocyte transcription factors PPARγ 
and CEBPα that have previously been mapped using ChIP-seq in subcutaneous adipocytes derived by differ-
entiation of primary human pre-adipocytes35 or the established SGBS human cell line model, Schmidt, et al.36. 
We found that PPARγ binding regions identified in the primary subcutaneous adipocyte model35 were strongly 
enriched for low levels of methylation in SA (Fig. 5a, x-axis). In contrast, the same PPARγ sites showed inter-
mediate levels of methylation in VA samples and mostly high methylation in PBL DNA. SGBS cells showed a 
similar trend of enrichment, with binding sites for PPARγ and CEBPα overlapping regions of low SA methylation 
(Supplementary Fig. S12). These data highlight the relationship between transcription factor binding and DNA 
methylation and reveal differences in DNA methylation between SA, VA and PBL at binding sites for the adipo-
genesis regulatory TFs PPARγ and CEBPα.
Looking more broadly at the binding of other TFs we utilised the set of ChIP-characterised binding sites for 
161 factors curated by the ENCODE Consortium37, across many different cell types. For each TF we mapped the 
presence of ChIP-determined binding sites within UMRs and LMRs common to SA and VA, but not PBL, and SA/
VA DMRs that distinguish differences in methylation between VA and SA. Across all methylation features, bind-
ing sites were highly enriched both for general transcription proteins such as POLR2A and proteins associated 
with chromatin architecture (EP300, CTCF, RAD21), as well as sequence-specific TFs (Fig. 5b, Supplementary 
Table S23). Indeed approximately 90% of tested TFs showed high level enrichment with the features (p < 0.001, 
hypergometric test, Supplementary Table S23). Within the set of SA/VA DMRs, all nine sequence-specific TFs 
with binding sites in ≥5% of DMRs, including CEBPβ (11.2%), FOS (9.0%) and PPARγ (7.7%), are of known 
importance in adipocyte biology (Fig. 5b).
Comparison of TF binding within LMRs and UMRs that were shared by SA and VA and not PBL, with those 
found only in PBL showed that these shared UMRs and LMRs were enriched in binding sites of known TFs 
important in adipocyte biology such as PPARγ (Fig. 5b, Supplementary Tables S23 and S24). The ZNF423 and 
CEBPA genes, important regulators of adipogenesis, harbour adipocyte-specific UMRs and LMRs respectively, 
which are bound by multiple TFs (Supplementary Figs S12, S13).
To explore whether LMRs could be used to identify putative, functionally important, enhancer elements that 
were specific to each cell type, we investigated the relationship between differentially expressed genes and TF 
binding in LMRs specific to SA or VA. We separately chose SA and VA LMRs with the lowest 25% of methylation 
(these LMRs displayed the highest enrichment of active histone marks in SA – Fig. 4b) and overlapped these 
with VA- or SA-DMRs respectively. This process identified potential enhancer elements showing distinct differ-
ences in DNA methylation between SA and VA, which we termed SA D-LMRs (4,986) and VA D-LMRs (862) 
(Supplementary Table S25). Of the 3,455 genes that are the nearest protein coding genes to these D-LMRs, ~22% 
were differentially expressed compared with 13% of all protein-coding genes (χ2 = 176.5, two-tailed p < 2.2e-
16). By overlapping D-LMRs with ChIP-seq binding peaks (Supplementary Tables S26, S27) we found similar 
enrichment levels for many of the same TFs in both SA and VA D-LMRs (Supplementary Fig. S13). This sug-
gests that, in many instances, the same key DNA binding factors utilise different enhancer elements in SA and 
VA. Unsupervised clustering of SA D-LMRs and TF binding sites (Fig. 5c) shows clustering of groups of TFs 
associated with subsets of the LMRs. A similar pattern of clustering is seen for VA D-LMRs (Supplementary 
Fig. S14). The most prominent cluster (A) identifies LMRs that contain binding sites for the adipocyte TFs PPARγ 
and CEBPβ, STAT3, as well as a set of common transcriptional regulators and chromatin modifiers, including 
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Figure 5. Association of Transcription Factor Binding Sites with DNA Methylation Features. (a) Density plot 
of the relative frequency of SA PPARγ ChIP-seq peaks, y-axis35, against the level DNA methylation within 
these regions (x-axis) determined from our SA, VA, PBL WGBS data. (b) Plots of frequencies of the presence 
of transcription factor (TF) ChIP-seq peaks within DNA methylation features: DMRs (left panel), and UMRs 
(centre panel) and LMRs (right panel) in SA and VA, but not PBL. Blue bars are TFs involved in general 
transcriptional regulation or chromatin architecture, Pink bars are TFs involved in adipocyte biology, and 
grey bars are TFs involved in neither. (c) Unsupervised cluster plot of the presence (yellow) or absence (red) of 
ChIP-seq peak for 162 TFs (vertical axis) within 4,986 SA D-LMRs (horizontal axis). TF clusters A-F represent 
clusters of regions containing binding sites for common set of TFs. (d) UCSC browser image of PLIN4. Upper 
panel = broad view (1x zoom): SA D-LMR (orange), SA RNA-seq (orange), VA RNA-seq (purple). Lower 
panel = zoomed in view (12x zoom) of SA D-LMR (orange) and WGBS methylation tracks: VA Meth (purple) 
and SA Meth (orange) as well as PPARγ ChIP-seq (yellow and orange)35 and various transcription factor ChIP-
seq peaks (grey bars)37. (e) Plot comparing the percentage of High (ΔMe ≥ 0.3) and Low (ΔMe 0.1 to <0.3) 
DMRs that contain particular TF ChIP-seq peaks [ENCODE35]. A ratio was generated with the percentage of 
High DMRs containing ChIP-seq peaks over the percentage of Low DMRs for each TF. This ratio was plotted 
on a log2 scale – x-axis. Selected TFs are highlighted in text and by red (positive ratio) and yellow (negative 
1 0Scientific RepoRts |          (2019) 9:9511  | https://doi.org/10.1038/s41598-019-45777-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
EP300, POL2RA, MAX, MYC and FOS/JUN family members. Additional clusters identify sets of TFs that might 
also commonly co-operate in gene regulation (discussed in Supplementary Information). For example, cluster 
F includes the TF NR2F2 that has been shown to be a critical regulator of adipogenesis38. More than 50% of SA 
D-LMRs containing binding sites for NR2F2 also contain binding sites for TEAD4, GATA2, TAL1, CEBPβ and 
PPARγ These enriched clusters of TF binding sites are consistent with the LMRs having transcriptional regulatory 
roles in adipocyte differentiation and function.
To locate potential regulatory regions distinguishing SA and VA we identified D-LMRs associated with mul-
tiple TFs and overlapped these with genes differentially expressed in VA and SA. This process identified LMRs 
potentially regulating expression of specific genes involved in adipocyte function (Supplementary Information) 
including F13A1, the Wnt signaling receptor LRP5 (Supplementary Fig. S14), SLC2A5, CIDEC and TPCN2. The 
example of PLIN4 (LMR in Cluster B) a protein essential to lipid droplet formation in adipocytes39 is shown in 
Fig. 5d. Together these examples point to the potential to utilise DNA methylation profiles combined with TF 
binding data to identify candidate genomic regions involved in regulation of adipocyte gene expression.
The most differentially methylated regions overlap with Polycomb Repressive Complex 2 bind-
ing regions. Given the strong association of High SA/VA DMRs, with developmental regulators, in contrast 
to Low DMRs, we next investigated whether they might be preferentially bound by different transcription factors. 
Consistent with the association of Low DMRs with genes involved in metabolic/cellular functions, binding sites 
for TFs such as RXRα (PPARγ binding partner), the glucocorticoid receptor (NR3C1), and TFAP2 family mem-
bers are among those showing modest enrichment (Fig. 5e – negative values, Supplementary Table S28). For both 
SA and VA, High DMRs were strongly enriched in binding sites for SUZ12 and EZH2 (Fig. 5e), core subunits 
of the Polycomb Repressive Complex 2 (PRC2), an important regulator in early development10. Interestingly, 
CTBP2, which is involved in early lineage commitment through recruitment of the NuRD and PRC2 complexes40 
and plays a direct role in adipogenesis41,42, was also highly enriched.
To further explore the relationship between High DMRs and developmental pathways we investigated public 
data of PRC2 binding sites (EZH2/SUZ12 peaks) in embryonic stem cells (ESCs)37. We overlapped SA/VA pro-
moter DMRs with EZH2/SUZ12 peaks from ESCs and found that the higher the ΔMe the more likely the regions 
were to be bound by EZH2/SUZ12 in ES cells. Of the protein coding genes with promoter associated Low DMRs 
only 9% had promoters bound by EZH2/SUZ12 in ESC, in contrast to 34% of protein coding genes with High 
DMRs (Fig. 5f) (χ2 216.7, p < 2.2e-16). As genes with High DMR promoters were also frequently differentially 
expressed, these findings highlight how, through DNA methylation, events that occur in early development may 
later influence gene expression and cell function in mature adipocytes.
Discussion
To further our understanding of the molecular differences between subcutaneous and visceral adipocytes, we 
have developed the first comprehensive DNA methylome and transcriptome maps of adipocytes isolated from 
healthy weight individuals. The gene expression data highlights that many of the functional differences seen in 
transcriptome analysis of adipose tissue are substantially contributed to by the adipocytes themselves, for example 
in the processes of angiogenesis, extracellular matrix organisation and inflammatory responses. DNA methyla-
tion profiles were notably distinct between the different adipocyte depots. The most striking differential meth-
ylation that separated VA and SA was found at transcription factor and developmental genes and these regions 
were subject to polycomb repression early in development. These findings highlight that early cell fate decisions 
and different developmental origins are reflected in the differential DNA methylation landscapes of SA and VA.
Analysis of differential methylation identified a clear difference between High (ΔMe ≥ 0.3) and Low (ΔMe, 
0.1–0.3) DMRs. High DMRs were positively associated with developmental TFs, while low DMRs were enriched 
for pathways related to cellular metabolism, extracellular matrix and responses to external signals. Likewise, many 
genes that had promoter DMRs and were differentially expressed have recognised roles in the biology of fat tissue, 
indicating the importance of DNA methylation in shaping the differential biological properties of adipose depots. 
DNA methylation profiles across both VA and SA were used to identify potential active promoters and enhancers 
(UMRs and LMRs respectively). The clear clustering of groups of transcription factors on subsets of LMRs and 
UMRs is indicative of specific combinations of TFs co-operating in adipocyte gene regulation. Combining gene 
expression data with specific regulatory (UMRs or LMRs) elements that are shared (eg., CEBPA gene) or differ (eg 
LRP5 gene) between SA and VA provides a pathway to use this catalogue of cis-regulatory elements for identifica-
tion and study of putative regulatory regions controlling differential gene function in adipocytes.
An unexpected feature observed at a number of genes with higher relative differential expression, was the 
presence of hypermethylated promoter DMRs. Many of these “same direction” DE-DM genes (eg. HOXC10 and 
GATA2) demonstrated a sharp delineation of the DNA methylation profile at the active promoter region; we 
coined these DMRs methylation ‘cliffs’. A similar feature of differential methylation bordering and potentially 
defining promoter boundaries has been seen in the differentiation of hematopoetic stem cells to mature cells of 
the myeloid and lymphoid lineages43. Recent work from Li et al.44 also identified a similar relationship in mouse 
tissues where they found a subset of dynamic DMVs that exhibited a positive correlation between DNA methyla-
tion and gene expression. Likewise, they found that these genes were enriched for TFs. Based on the observation 
ratio) bars. (f) Barplot of protein coding genes stratified into, all protein coding promoters (All), and those with 
promoter DMRs between 0.1 to <0.3, 0.3 to <0.4, and ≥0.4. The percentage of these genes are then split by 
whether their promoters are bound by PRC2 in ES cells (grey)37 or are not bound by PRC2 in ES cells (black). 
Y-axis = percentage of promoters that contain ESC PRC2 ChIP-seq peaks or not, x – axis = gene stratification.
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of these “same direction” DE-DM genes we speculate that, when broadly unmethylated, these regions are associ-
ated with repressive chromatin marks (PRC2-dependent), and that modelling of the active state involves removal 
of repressive chromatin that covers the active promoter. This is accompanied by methylation of the cliff regions 
that flank the core active promoter, thus limiting the encroachment of repressive chromatin.
Relative to other cell types in the body SA and VA are morphologically and functionally very similar, pro-
viding an ideal model to examine how the epigenome helps to define cell type. As mentioned above we find that 
the transcriptional differences between SA and VA match well with known differences in functional pathways. 
However, the most striking contrast is in their differential methylation where there is a clear enrichment of devel-
opmental genes, particularly for High DMRs. Previous studies have demonstrated that a cell’s DNA methylation 
profile provides an epigenetic memory of its developmental lineage45–47. Unlike many of the organs and tissues 
that arise from the mesoderm, such as kidney, gonad and limb, the process of development of the adipose depots 
is poorly described. Interestingly we find here that many of the differentially expressed and methylated TFs are 
genes important in the developmental processes of regionalization and positional identity. Differential expres-
sion and methylation of the PITX, HOX and TBX families, suggests that, like in the regionalization processes for 
other tissues, these genes may play a role in defining visceral from subcutaneous depots. Developmental genes, 
including HOX and TBX family members, have been shown at the tissue level to be differentially expressed across 
different fat depots including between omental VAT and abdominal SAT31. Our data on isolated SA and VA sig-
nificantly extends the suite of developmental genes whose expression distinguishes abdominal subcutaneous and 
visceral tissues and demonstrates that many of these genes carry distinct epigenetic marks in their promoters. 
Indeed, this set of genes includes many of those with the largest DMRs. The promoters of TFs enriched for high 
magnitude DMRs were also enriched for PRC2 binding in ESCs. This further supports the role of these genes as 
lineage differentiation factors10, as genes repressed by PRC2 in early development and very likely regulated by 
promoter DNA methylation in mature adipocytes. The strong enrichment for promoter High DMRs at TFs that 
are differentially expressed, suggests that these regions are not simply residual markings left over from develop-
mental history, but that they are important in regulating transcriptional activity in mature adipocytes. These data 
also support the idea that DNA methylation may play a particularly important role in regulating TFs, compared 
to other genes.
Lineage tracing experiments in mice have shown that visceral, in contrast to subcutaneous, adipocytes are 
derived from Wt1-expressing cells of the lateral plate mesoderm30. Elevated relative expression of WT1 in VA 
and differential promoter methylation of >30% also supports that the lateral plate mesoderm is a source of vis-
ceral adipocytes in humans. In contrast to visceral depots, the developmental origins of subcutaneous depots 
remain largely unknown30. Here we see numerous developmental transcription factors that are epigenetically 
marked and overexpressed in SA relative to VA. These genes, including HOXC10, TBX4 and PITX2, provide a 
gene expression and DNA methylation signature indicative of the different development origins of SA and VA. 
Interestingly in mice, Tbx4/5, Pitx1/2 and numerous Hox genes (including HoxC9/10) are expressed in the lateral 
plate mesoderm48,49 and regulate limb development. The fore- and hindlimbs have also been shown to arise from 
different sub-domains of the lateral plate mesoderm and their development is differentially regulated by key TF 
genes Tbx4 and HoxC10 (hind-limbs) and Tbx5 (fore-limbs)49. Similarly, we hypothesize that progenitors from 
different mesoderm sub-domains give rise to the origin of VA and SA, and this is dependent on whether the cells 
either express WT1 (VA) and different combinations of TBX, HOX and PITX genes. Recently, HOXC10, TBX4/5 
and PITX1 proteins have been shown to cooperate in development of mouse limb buds, with HOXC10 and TBX4 
interacting directly to control a common set of downstream genes50. This raises the possibility that HOXC10 
interacting with TBX4, along with PITX2 (all expressed in SA) may also cooperate in driving development of the 
subcutaneous pre-adipocyte lineage. The differential role of TBX5 gene expression in abdominal and gluteal SAT 
depots51 exemplifies the significance of such lineage differentiation factors. TBX5 is both differentially methylated 
and expressed between the depots, and knockdown of TBX5 expression affected proliferation and differentiation 
of abdominal SAT preadipocytes.
Overall, these findings highlight that early cell fate decisions are reflected in the methylomes of SA and VA, 
with major differences in methylation strongly enriched around genes important in development. These data 
support the hypothesis that early developmental events are important in defining the transcriptional profiles of 
SA and VA, and that these differences are established and maintained, at least in part, by DNA methylation. This 
concept is likely to be common to other cell types and demonstrates that WGBS mapping provides a powerful 
approach to interrogate gene regulation and lineage history.
Methods
subjects and tissue samples. Three normal weight female subjects undergoing elective surgery were 
recruited under the study protocol approved by the St Vincent’s Hospital Human Research and Ethics Committee, 
SVH File Numbers: H06/151 and 12/200. All subjects gave informed consent for participation. All experiments, 
data collection and storage conformed to the approved study protocol, and in accordance with relevant guidelines 
and regulations. The women were aged 35–47, with BMIs ranging from 19.1 to 25.4. Further details on subjects is 
available in Supplementary Information and Supplementary Table S1.
VAT was collected from the greater omental region and SAT from the periumbilical site of surgical inci-
sion. Details of methods for tissue processing, adipocyte isolation and nucleic acid isolation are provided in 
Supplementary Information.
DNA Methylome analysis. Whole genome bisulfite sequencing libraries were prepared from 1 µg of DNA 
following Illumina’s “Whole- Genome Bisulfite sequencing for Methylation Analysis” protocol. Three lanes of 
paired end 100 bp sequencing was performed for each of the library on the Illumina HiSeq2500 platform using 
the TruSeq v3 cluster kits and SBS kits to achieve coverage ranging between 25–30x. (details in Supplementary 
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Table S1). Supporting DNA methylome data on the core and two healthy weight male subjects was obtained 
using Illumina Infinium Bead Chip Human450 arrays. Further experimental details, details of quality assess-
ment and sequence alignment, and analysis of differential methylation and methylation profiles are provided in 
Supplementary Information and Supplementary Table S1.
Gene expression. Libraries for Poly-A and Whole RNA-seq were prepared from 500 ng input RNA using the 
Illumina TruSeq Stranded poly-A RNA Library Prep Kit RNA-seq and following ribosomal RNA reduction using 
Illumina TruSeq Stranded Total RNA Library Prep Kit respectively. Poly-A RNA-seq libraries were sequenced 
using 100 bp paired-end HiSeq2500 chemistry3 yielding at least 30 million reads per sample, Supplementary 
Table S1. Whole RNA-seq libraries were sequenced using 100 bp paired-end HiSeq2500 chemistry4 yielding 35 
to 40 million aligned reads per sample (see Supplementary Information and Supplementary Table S1). Details of 
quality checking, mapping of reads to the genome, and to genes/transcripts, calling of differential gene/transcript 
expression and Gene Ontology analysis are provided in Supplementary Information.
Data access. Whole genome bisulfite sequencing data, RNA sequencing data and DNA methylation array 
data from this study are available from the NCBI’s Gene Expression Omnibus repository (GEO; http://www.ncbi.
nlm.nih.gov/geo/) under the series accession number GSE110821.
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